The iNCDSS is an AI-driven tool that uses electronic health records incorporating typical characteristics of the general T2D population to output real-time and personalized insulin titration covering the most commonly used subcutaneous insulin regimens in T2D.19 Suboptimal glycemic control for inpatients with T2D often results in prolonged hospital stays and poor clinical outcomes,33 whereas the iNCDSS offers a pragmatic solution to optimal insulin titration. Here, INS is linked to type 2 diabetes mellitus.